Clinical Trial: A Single Ascending Dose Study of DTI-117 Given Intramuscularly in Healthy Participants.

U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07882472) titled 'A Single Ascending Dose Study of DTI-117 Given Intramuscularly in Healthy Participants.' on Oct. 13.

Brief Summary: This is a single ascending dose, double-blind, placebo-controlled, randomized evaluation of the safety, tolerability, and pharmacokinetics of DTI-117 in healthy volunteers. There will be up to five cohorts of 8 healthy participants each cohort.

Study Start Date: Oct., 2026

Study Type: INTERVENTIONAL

Condition: Healthy Adult

Intervention: DRUG: DTI-117

DTI-117 or matching placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Dignify Therapeutics

Disclaimer: Curated by HT Syndication....